Thursday, June 6, 2013

Free??? Gardasil HPV Vaccine NOT Tested for Carcinogens & Causes Cancer!

With Michael Douglas
recent declaration that he "got cancer" by performing oral sex on too many women -- and here's the proof recording of him saying this even though he later denied it -- actor Michael Douglas joins the long list of Hollywood celebrities who embarrass themselves by repeating absurd lies told to them by cancer doctors.

If having oral sex with women gives you cancer, then Charlie Sheen should be the world's most monstrous walking tumor. But he isn't. That's because oral sex doesn't cause cancer. It's a delusional medical myth dreamed up by the vaccine industry to sell HPV vaccines to the masses by linking them to common sex acts. 

Malaysian girls will soon start dying...

Free HPV Jabs For College Girls Soon

Tuesday, 28 May 2013 13:23 

KUALA LUMPUR: The government will introduce a human papillomavirus (HPV) vaccination for college-going girls to prevent cervical cancer.

Health Minister Datuk Seri Dr S. Subramaniam said the ministry was discussing the details with the Women, Family and Community Development Ministry as well as the National Population and Family Development Board.
"We believe such a life-saving endeavour must not only be limited to adolescent girls," said Dr Subramaniam, whose speech was read by the deputy director-general of health Datuk Dr Maimunah Hamid at the Global Forum on Cervical Cancer Prevention here yesterday.

He said Malaysia was the first country in Southeast Asia and one of the first in Asia, to implement a National HPV Immunisation Programme.

"We know that these vaccines work best when given to adolescent girls. Free HPV vaccines through a school-based programme were provided to 13-year-olds in government and private schools.

"Until now, more than 95 per cent of eligible girls have received all three doses of the vaccine."

Malaysia began its cervical cancer screening programme more than 40 years ago and over the years, has worked to strengthen it.

 

I also posted a report on Gardasil last year:
By  | May 13th, 2012

When we see the term “cancer vaccine” in connection with the HPV (human  papilloma virus) vaccine Gardasil we may naturally assume that  it prevents cervical cancer, yet there is no evidence whatsoever that this is the case. (1)  On the contrary, the term is incorrect because unbelievable though it may sound Gardasil may actually cause cancer. This fact is being ignored by Merck the manufacturer and other promoters including doctors and health authorities.

NOT TESTED FOR CARCINOGENICITY

Information in the package insert states that the vaccine has not been tested for carcinogenicity. (2) Why has this not been done?  Absence of evidence is not evidence of absence!  There appears to be no official requirement for vaccines to be tested for carcinogenicity and no incentive for manufacturers to do so.  Many experts consider that vaccines are conducive towards the dramatic worldwide increase in cancer cases.

REPLACEMENT MAY CAUSE DEVELOPMENT OF CANCER

A normal phenomenon in virology is that virus strains which have been removed are replaced by new ones.  It is not known by anyone, including the vaccine manufacturer  whether the new virus strains are more carcinogenic than the original ones which have been removed.
The chief editor of the Journal of the Norwegian Medical Association, immunologist Charlotte Haug writes about several unanswered questions including that of replacement in her article “We Need to Talk about HPV Vaccination – Seriously”:
Abhorred vacuum.There is another serious question that may be answered sooner:  what effect will the vaccine have on the other cancer-causing strains of HPV? Nature never leaves a void, so if HPV-16 and HPV-18  are suppressed by an effective vaccine, other strains of the virus will take their place. The question is, will these strains cause cervical cancer?
Results from clinical trials are not encouraging. Vaccinated women show an increased number of precancerous lesions caused by strains of HPV other than HPV-16 and HPV-18. The results are not statistically significant, but if the trend is real – and further clinical trials should tell us in a few years – there is reason for serious concern. (3)
In an article in the New England Journal of Medicine  “ Human Papilloma Virus Vaccination – Reasons for Caution”,  Dr. Haug again poses the question of replacement:
“How will the vaccine affect other oncogenic strains of HPV? If HPV-16 and HPV-18 are effectively suppressed, will there be selective pressure on the remaining strains of HPV? Other strains may emerge as significant oncogenic serotypes”. (4)

Replacement was obviously one of several  unanswered questions when FDA, Merck and the Norwegian government signed a contract which involved research studies on  thousands of young Norwegian schoolgirls. The agreement was that Gardasil would be approved in US under the condition that extensive research projects were carried out in Norway. There was implication of corruption in connection with introduction of Gardasil in the childrens’ vaccination program. (5)
The contract includes this statement from FDA to Merck:
“You have committed to conduct a study in collaboration with the Norwegian Government, if GARDASIL  is approved in the European Union and the Government of Norway incorporates HPV vaccination into its national guidelines, to assess the impact of HPV vaccination on the following in Norway … to assess whether administration of GARDASIL will result in replacement of these diseases due to vaccine HPV types with diseases due to non-vaccine HPV types.” (6)

ABNORMAL PAP SMEARS AFTER GARDASIL VACCINATION

It is worrying to note that many cases of abnormal Pap smears, cervical dysplasia and cervical cancer are registered after Gardasil vaccination. Reports from VAERS, the Vaccine Adverse Event Reporting System regarding HPV vaccines are regularly published by SaneVax.(7)  The numbers registered with VAERS may be as low as one percent of the actual cases.

INCREASE IN CERVICAL CANCER RISK FOR THOSE PREVIOUSLY EXPOSED TO THE HUMAN PAPILLOMA VIRUS

One of the most disturbing observations which deserves serious investigation  concerns the considerable potential  increase in risk of cancer after Gardasil vaccination for those who have been pre- exposed to the human papilloma virus. 

Sanevax writes:
Peer-reviewed analysis and studies many of them on the FDA, NCI and CDC web sites point out the dangers of many of the vaccine ingredients including the potential for the HPV vaccines to increase the risk for pre-cancerous lesions if adolescents have been previously exposed to the human papillomavirus and then get vaccinated: 44.6% increase post Gardasil.
Judicial Watch writes in their Special Report “Examining The FDA’s HPV Vaccine Records”:
A chart in the committee’s report revealed that efficacy in subjects already exposed to “relevant HPV types” had an observed efficacy rate of -44.6%. The disturbing efficacy rate raises questions as to who should be receiving the vaccine, and why the FDA allows Gardasil to be administered without prescreening for HPV. The outcomes that can result from pre-exposure are disconcerting and deserve far more attention.(8)



No comments: